Through in vivo and in vitro experiments, we confirmed that SESN2 could inhibit this “infection” through the reduction of exosome release by promoting autophagic degradation; Rab-7a-mediated autophagosome and lysosome fusion and TFEB-mediated lysosomal function repair may play roles in this process. The gene discussed is SESN2; the disease is infection.